NUTRItional Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double Blind, Placebo-controlled Trial of the Motilin Receptor Agonist GSK962040. The NUTRIATE Study

Trial Profile

NUTRItional Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double Blind, Placebo-controlled Trial of the Motilin Receptor Agonist GSK962040. The NUTRIATE Study

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2016

At a glance

  • Drugs Camicinal (Primary) ; Metoclopramide
  • Indications Gastroparesis
  • Focus Therapeutic Use
  • Acronyms The NUTRIATE Study
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 23 Nov 2016 Status changed from recruiting to completed.
    • 10 Nov 2015 Planned End Date changed from 1 Sep 2015 to 1 Aug 2016 as reported by Clinicaltrials.gov record.
    • 10 Nov 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Aug 2016 as reported by Clinicaltrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top